On March 29, 2012, the Food and
Drug Administration (FDA) issued a recall of GranuFlo and NaturaLyte. These products were manufactured by Fresenius
Medical Care and were used to treat kidney disease and kidney failure. According to the FDA, the use of these
products could lead to low blood pressure and cardiac arrhythmia.
Fresenius was aware of these dangers, but did not share that
information with health care providers or consumers. These
products were used in numerous dialysis facilities, not just those owned by
Fresenius.
Several hundred cases involving
GranuFlo and NaturaLyte have been consolidated into Multi-District Litigation
in the United States District Court for the District of Massachusetts.
If you or a loved one has
experienced a sudden cardiac event during or soon after dialysis treatment,
please give us a call to learn more about your legal rights.
Teresa E. Harvey
No comments:
Post a Comment